Abstract

Tissue-engineered heart valves are proposed as novel viable replacements granting longer durability and growth potential. However, they require extensive in vitro cell-conditioning in bioreactor before implantation. Here, the propensity of non-preconditioned decellularized heart valves to spontaneous in body self-regeneration was investigated in a large animal model. Decellularized porcine aortic valves were evaluated for right ventricular outflow tract (RVOT) reconstruction in Vietnamese Pigs (n = 11) with 6 (n = 5) and 15 (n = 6) follow-up months. Repositioned native valves (n = 2 for each time) were considered as control. Tissue and cell components from explanted valves were investigated by histology, immunohistochemistry, electron microscopy, and gene expression. Most substitutes constantly demonstrated in vivo adequate hemodynamic performances and ex vivo progressive repopulation during the 15 implantation months without signs of calcifications, fibrosis and/or thrombosis, as revealed by histological, immunohistochemical, ultrastructural, metabolic and transcriptomic profiles. Colonizing cells displayed native-like phenotypes and actively synthesized novel extracellular matrix elements, as collagen and elastin fibers. New mature blood vessels, i.e. capillaries and vasa vasorum, were identified in repopulated valves especially in the medial and adventitial tunicae of regenerated arterial walls. Such findings correlated to the up-regulated vascular gene transcription. Neoinnervation hallmarks were appreciated at histological and ultrastructural levels. Macrophage populations with reparative M2 phenotype were highly represented in repopulated valves. Indeed, no aspects of adverse/immune reaction were revealed in immunohistochemical and transcriptomic patterns. Among differentiated elements, several cells were identified expressing typical stem cell markers of embryonic, hematopoietic, neural and mesenchymal lineages in significantly higher number and specific topographic distribution in respect to control valves. Following the longest follow-up ever realized in preclinical models, non-preconditioned decellularized allogeneic valves offer suitable microenvironment for in vivo cell homing and tissue remodeling. Manufactured with simple, timesaving and cost-effective procedures, these promising valve replacements hold promise to become an effective alternative, especially for pediatric patients.

Highlights

  • Bioprosthetic and mechanical substitutes are currently unique therapeutic options for the rising concern of heart valve disease, affording time-limited or unsatisfactory biocompatibility [1].Implanted bioprostheses degenerate following calcific nucleation on cell remnants, interesting fragmented collagen/elastin fibers and/or depending on the mineralization potential of glutaraldehyde (GA) residues [2,3,4]

  • Endowed with a tridimensional extracellular matrix (ECM) architecture for satisfactory heart valve physiology, decellularized native tissues are used as scaffolds to be cell-seeded and stimulated in bioreactors for the achievement of mature bioengineered replacements [1]

  • The present study focuses on the ex vivo evaluation of valve recolonization and demonstrates effective tissue regeneration of decellularized heart valve scaffolds by recipient’s cells after this long-term follow-up

Read more

Summary

Introduction

Bioprosthetic and mechanical substitutes are currently unique therapeutic options for the rising concern of heart valve disease, affording time-limited or unsatisfactory biocompatibility [1]. Implanted bioprostheses degenerate following calcific nucleation on cell remnants, interesting fragmented collagen/elastin fibers and/or depending on the mineralization potential of glutaraldehyde (GA) residues [2,3,4]. GA treatment stabilizes extracellular matrix (ECM) against chemical/enzymatic degradation and shields xenogeneic cell epitopes in porcine or bovine bioprostheses [5]. Several tissue-engineered heart valves (TEHVs) have been tested as alternative surgical solutions to nonviable bioprostheses. Endowed with a tridimensional ECM architecture for satisfactory heart valve physiology, decellularized native tissues are used as scaffolds to be cell-seeded and stimulated in bioreactors for the achievement of mature bioengineered replacements [1]. The manufacturing phases for their production are arduous to control and time-consuming

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.